Haemorrhagic stroke, overall stroke risk, and combined oral contraceptives: Results of an international, multicentre, case-control study

Lancet

Volumn 348, Issue 9026, 1996, Pages 505-510

  Poulter, N R ^a   Meirik, O ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b WORLD BANK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ORAL CONTRACEPTIVE AGENT;

ADULT; AGE; ARTICLE; BRAIN HEMORRHAGE; CIGARETTE SMOKING; DEVELOPING COUNTRY; EUROPE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; ORAL CONTRACEPTION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RISK ASSESSMENT; STROKE; SUBARACHNOID HEMORRHAGE;

EID: 0030600339     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(95)12394-6     Document Type: Article

References (32)

1. 1 Inman WHW, Vessey MP. Investigation of deaths from pulmonary, coronary and cerebral thrombosis and embolism in women of child-bearing age. BMJ 1968; ii: 193-99.
2. 2 Vessey MP, Doll R. Investigation of relation between use of oral contraceptives and thromboembolic disease: a further report. BMJ 1969; ii: 651-57.
3. 3 Sartwell PE, Masi AT, Arthes FG, Green GR, Smith HE. Thromboembolism and oral contraceptives: an epidemiological case control study. Am J Epidemiol 1969; 90: 365-80.
4. 4 Fogelholm R, Aho K. Ischaemic cerebrovascular disease in young adults. Acta Neurol Scand 1973; 49: 415-27.
5. 5 Collaborative Group for the Study of Stroke in Young Women. Oral contraceptives and stroke in young women. JAMA 1975; 231: 718-22.
6. 6 Jick H, Porter J, Rothman KJ. Oral contraceptives and non-fatal stroke in healthy young women. Ann Intern Med 1978; 88: 58-60.
7. 7 Mettinger KL, Soderstrom CE, Neiman J. Stroke before 55 years of age at Karolinska Hospital 1973-77: a study of 388 well-defined cases. Acta Neurol Scand 1984; 70: 415-22.
8. 8 Chang KK, Chow LP, Rider RV. Oral contraceptives and stroke: a preliminary report on an epidemiologic study in Taiwan, China. Int J Gynecol Obstet 1986; 24: 421-30.
9. 9 Thorogood M, Mann J, Murphy M, Vessey M. Fatal stroke and use of oral contraceptives: findings from a case-control study. Am J Epidemiol 1992; 136: 35-45.
10. 10 Lidegaard O. Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study. BMJ 1993; 306: 956-63.
11. 11 Ramcharan S, Pelligrin FA, Ray R, Hsu JP. The Walnut Creek contraceptive study. Centre for Population Research Monograph Number 81-564. Washington, DC: Government Printing Office, 1981.
12. 12 Royal College of General Practitioners. Further analysis of mortality in oral contraceptive users. Lancet 1981; i: 541-46.
13. 13 Layde PM, Ory HW, Beral V, Kay CR. Incidence of arterial disease among oral contraceptive users. J R Coll Gen Practitioners 1983; 33: 75-82.
14. 14 Vessey MP, Lawless M, Yeates D. Oral contraceptives and stroke: findings in a large prospective study. BMJ 1984; 289: 530-31.
15. 15 Stampfer MJ, Willet WC, Colditz GA, Speizer FE, Hennekens CH. A prospective study of oral contraceptive agents and risk of cardiovascular diseases. N Engl J Med 1988; 319: 1313-17.
16. 16 Petitti DB, Wingerd J. Use of oral contraceptives, cigarette smoking, and risk of subarachnoid haemorrhage. Lancet 1978; ii: 234-37.
17. 17 Inman WH. Oral contraceptives and fatal subarachnoid haemorrhage. BMJ 1979; ii: 1468-70.
18. 18 WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. A multinational case-control study of cardiovascular disease and steroid hormone contraceptives: description and validation of methods. J Clin Epidemiol 1995; 48 (suppl 12): 1513-47.
19. 19 WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. Lancet 1995; 346: 1575-82.
20. 20 WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception Group. Ischaemic stroke and combined oral contraceptives: results of an international multicentre case-control study. Lancet 1996; 348: 498-505.
21. 21 Hannaford PC, Croft PR, Kay CR. Oral contraception and stroke: evidence from the Royal College of General Practitioners' Oral Contraception Study. Stroke 1994; 25 (suppl 5): 935-42.
22. 22 Fisch IR, Freedman SH, Hyatt AV. Oral contraceptives, pregnancy and blood pressure. In: Ramcharan S, ed. The Walnut Creek contraceptive drug study: a propsective study of the side effects of oral contraceptives, volume 1. Washington, DC: Government Printing Office, 1974: 105-33.
23. 23 Ramcharan S, Pellagrin FA, Hoag EJ. The occurence and course of hypertensive disease in users and non-users of oral contraceptive drugs. In: Ramcharan S, ed. The Walnut Creek contraceptive drug study: a prospective study of the side effects of oral contraceptives, volume 2. Washington DC: Government Printing Office, 1976: 1-16.
24. 24 Weir RJ. Oral contraceptives, hormone replacement therapy and hypertension. In: Swales JD, ed. Textbook of hypertension. Oxford: Blackwell Scientific Publications, 1994.
25. 25 Prentice RL. On the ability of blood pressure effects to explain the relation between oral contraceptives and cardiovascular disease. Am J Epidemiol 1988; 127: 213-19.
26. 26 Royal College of General Practitioners' Oral Contraception Study. Mortality among oral-contraceptive users. Lancet 1977; ii: 727-31.
27. 27 Walter SD. The estimation and interpretation of attributable risk in health research. Biometrics 1976; 32: 829-49.
28. 28 Bonita R. Epidemiology of stroke. Lancet 1992; 339: 342-44.
29. 29 Mettinger KL, Soderstrom CE, Allander E. Epidemiology of acute cerebrovascular disease before the age of 55 in the Stockholm county, 1973-88. Stroke 1984; 15: 795-801.
30. 30 Schlesselman JJ. Case-control studies: design, conduct, analysis. New York: Oxford University Press, 1982.
31. 31 Petitti DB, Sidney S, Bernstein A, Wolf A, Queensberry C, Ziel HK. Stroke in users of low-dose oral contraceptives. N Engl J Med 1996; 335: 8-15.
32. 32 Vessey MP. The Jephcott lecture 1989: an overview of the benefits and risks of combined oral contraceptives. In: Mann RD, ed. Oral contraceptives and breast cancer. Carnforth, Lanes: Parthenon Publishing, 1990.